Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
13.56
-0.18 (-1.31%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Inhibrx Statistics
Total Valuation
Inhibrx has a market cap or net worth of $196.29 million. The enterprise value is $198.97 million.
Market Cap | 196.29M |
Enterprise Value | 198.97M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
Earnings Date | Aug 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Inhibrx has 14.48 million shares outstanding.
Shares Outstanding | 14.48M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 23.50% |
Owned by Institutions (%) | 28.21% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37
Current Ratio | 0.37 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 172 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 2.88 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 46.64 |
Average Volume (20 Days) | 333,561 |
Short Selling Information
The latest short interest is 884,068, so 6.11% of the outstanding shares have been sold short.
Short Interest | 884,068 |
Short Previous Month | 1.30M |
Short % of Shares Out | 6.11% |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | -$11.56 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | 2.68M |
Net Cash | -2.68M |
Net Cash Per Share | -$0.19 |
Equity (Book Value) | -10.77M |
Book Value Per Share | -0.74 |
Working Capital | -24.25M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Inhibrx does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |